Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database

BACKGROUND: Hepatotoxicity may be a concern when prescribing antidepressants. Nevertheless, this risk remains poorly understood for serotonin and noradrenaline reuptake inhibitors (SNRIs: venlafaxine, milnacipran, duloxetine) and ‘other antidepressants’ (mianserin, mirtazapine, tianeptine and agomel...

Descripción completa

Detalles Bibliográficos
Autores principales: Billioti de Gage, Sophie, Collin, Cédric, Le-Tri, Thien, Pariente, Antoine, Bégaud, Bernard, Verdoux, Hélène, Dray-Spira, Rosemary, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061298/
https://www.ncbi.nlm.nih.gov/pubmed/29959758
http://dx.doi.org/10.1007/s40263-018-0537-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061298/
https://www.ncbi.nlm.nih.gov/pubmed/29959758
http://dx.doi.org/10.1007/s40263-018-0537-1

Ejemplares similares